Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment-Reference-Cited by-同舟云学术

Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment

Published:2022-12-08 Issue:1 Volume:37 Page:1-4
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Claveau Jean-Sébastien^ORCID,Murray David L.^ORCID,Dispenzieri Angela^ORCID,Kapoor Prashant^ORCID,Binder Moritz^ORCID,Buadi Francis^ORCID,Dingli David^ORCID,Fonder Amie,Gertz Morie^ORCID,Gonsalves Wilson,Hayman Suzanne,Hobbs Miriam,Hwa Yi Lisa,Kourelis Taxiarchis^ORCID,Lacy Martha,Leung Nelson^ORCID,Lin Yi^ORCID,Warsame Rahma,Kyle Robert A.,Rajkumar Vincent,Kumar Shaji K.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-022-01779-8.pdf

Reference15 articles.

1. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21–33.

2. Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215–24.

3. Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Anderson K, et al. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467–73.

4. Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17:e328–e346.

5. van de Velde HJ, Liu X, Chen G, Cakana A, Deraedt W, Bayssas M. Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma. Haematologica 2007;92:1399–406.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone Marrow Morphology: A Key Diagnostic Tool in Various Hematological and Non Hematological Disorders;Pakistan Journal of Health Sciences;2024-08-31

2. Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma;Blood;2024-08-29

3. Az elérhető gyógyulás küszöbén: innovációk a myeloma multiplex kezelésében;Orvosi Hetilap;2024-06-09

4. Measurable Residual Disease and Decision-Making in Multiple Myeloma;Hematology/Oncology Clinics of North America;2024-04

5. Measurable residual disease in peripheral blood in myeloma: dream or reality;Current Opinion in Oncology;2023-08-13